Emla and Mucormycosis - a phase IV clinical study of FDA data
No or too few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
No or too few reports are found.
What is Emla?
Emla has active ingredients of lidocaine; prilocaine. Currently, eHealthMe is studying from 5,061 Emla users.
What is Mucormycosis?
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina) is found to be associated with 646 drugs and 610 conditions by eHealthMe. Currently, we are studying 4,334 people who have Mucormycosis.
Do you take Emla and have Mucormycosis?Check whether Mucormycosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Mucormycosis and when was it recovered:
Expand to all the drugs that have ingredients of lidocaine; prilocaine:
Alternative drugs to, pros and cons of Emla:
- Emla (5,061 reports)
Browse all side effects of Emla:a b c d e f g h i j k l m n o p q r s t u v w x y z
Mucormycosis treatments and more:
- Mucormycosis (4,334 reports)
All the drugs that are associated with Mucormycosis:
All the conditions that are associated with Mucormycosis:
How the study uses the data?
The study uses data from the FDA. It is based on lidocaine; prilocaine (the active ingredients of Emla) and Emla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Celexa and Fluphenazine drug interaction - a second ago
- Prednisone and B-Cell Small Lymphocytic Lymphoma - 17 seconds ago
- Insomnia and Skin Burning Sensation - 18 seconds ago
- Inrebic and Glipizide drug interaction - 23 seconds ago
- Maxalt and Tranexamic Acid drug interaction - 30 seconds ago
- Arimidex and Blood Calcium Increased - 38 seconds ago
- Cipro and Idiopathic Pulmonary Fibrosis - 43 seconds ago
- Skyrizi and Taltz drug interaction - 54 seconds ago
- Methylprednisolone and Chronic Respiratory Failure - 57 seconds ago
- Oxycodone And Acetaminophen and Benazepril Hydrochloride drug interaction - a minute ago